Efficacy of infliximab on MRI‐determined bone oedema in psoriatic arthritis
AUTOR(ES)
Marzo‐Ortega, Helena
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1954680Documentos Relacionados
- A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis
- Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
- Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis
- High‐grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone
- Rheumatoid arthritis bone erosion volumes on CT and MRI: reliability and correlations with erosion scores on CT, MRI and radiography